###begin article-title 0
###xml 57 75 57 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma brucei</italic>
###xml 105 113 105 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. cruzi</italic>
###xml 113 114 113 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fn" rid="N0x1da9930N0x2ee6090">&#9734;</xref>
###xml 113 114 113 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="fn" rid="N0x1da9930N0x2ee6090">&#9734;</xref></sup>
###xml 57 75 <span type="species:ncbi:5691">Trypanosoma brucei</span>
###xml 105 113 <span type="species:ncbi:5693">T. cruzi</span>
Comparative structural, kinetic and inhibitor studies of Trypanosoma brucei trypanothione reductase with T. cruziâ˜†
###end article-title 0
###begin p 1
Current address: York Structural Biology Group, Department of Chemistry, University of York, Heslington, York YO10 5DD, UK.
###end p 1
###begin p 2
This document may be redistributed and reused, subject to .
###end p 2
###begin title 3
Abstract
###end title 3
###begin p 4
###xml 141 159 141 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma brucei</italic>
###xml 331 339 331 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. cruzi</italic>
###xml 422 423 418 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 423 424 419 420 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 462 471 458 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. brucei</italic>
###xml 507 515 503 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. cruzi</italic>
###xml 587 588 583 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 588 589 584 585 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 608 617 604 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. brucei</italic>
###xml 780 781 775 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 781 782 776 777 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 958 960 953 955 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 69 74 <span type="species:ncbi:9606">human</span>
###xml 141 159 <span type="species:ncbi:5691">Trypanosoma brucei</span>
###xml 331 339 <span type="species:ncbi:5693">T. cruzi</span>
###xml 462 471 <span type="species:ncbi:5691">T. brucei</span>
###xml 507 515 <span type="species:ncbi:5693">T. cruzi</span>
###xml 608 617 <span type="species:ncbi:5691">T. brucei</span>
As part of a drug discovery programme to discover new treatments for human African trypanosomiasis, recombinant trypanothione reductase from Trypanosoma brucei has been expressed, purified and characterized. The crystal structure was solved by molecular replacement to a resolution of 2.3 A and found to be nearly identical to the T. cruzi enzyme (root mean square deviation 0.6 A over 482 Calpha atoms). Kinetically, the Km for trypanothione disulphide for the T. brucei enzyme was 4.4-fold lower than for T. cruzi measured by either direct (NADPH oxidation) or DTNB-coupled assay. The Km for NADPH for the T. brucei enzyme was found to be 0.77 muM using an NADPH-regenerating system coupled to reduction of DTNB. Both enzymes were assayed for inhibition at their respective S = Km values for trypanothione disulphide using a range of chemotypes, including CNS-active drugs such as clomipramine, trifluoperazine, thioridazine and citalopram. The relative IC50 values for the two enzymes were found to vary by no more than 3-fold. Thus trypanothione reductases from these species are highly similar in all aspects, indicating that they may be used interchangeably for structure-based inhibitor design and high-throughput screening.
###end p 4
###begin title 5
Abbreviations
###end title 5
###begin title 6
Keywords
###end title 6
###begin title 7
Introduction
###end title 7
###begin p 8
###xml 0 18 0 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma brucei</italic>
###xml 267 284 267 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. b. rhodesiense</italic>
###xml 289 304 289 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. b. gambiense</italic>
###xml 330 333 330 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib1" ref-type="bibr">[1]</xref>
###xml 500 503 500 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib2" ref-type="bibr">[2]</xref>
###xml 505 517 505 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. b. brucei</italic>
###xml 655 664 655 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. brucei</italic>
###xml 777 778 777 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 778 779 778 779 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 781 782 781 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 782 783 782 783 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 813 816 813 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib3" ref-type="bibr">[3]</xref>
###xml 1188 1189 1188 1189 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1221 1222 1221 1222 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1258 1259 1258 1259 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1322 1328 1322 1328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 1330 1333 1330 1333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib4" ref-type="bibr">[4]</xref>
###xml 1587 1590 1587 1590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib5" ref-type="bibr">[5]</xref>
###xml 1665 1668 1665 1668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib6" ref-type="bibr">[6]</xref>
###xml 0 18 <span type="species:ncbi:5691">Trypanosoma brucei</span>
###xml 140 145 <span type="species:ncbi:9606">human</span>
###xml 508 517 <span type="species:ncbi:497498">b. brucei</span>
###xml 557 563 <span type="species:ncbi:9913">cattle</span>
###xml 647 653 <span type="species:ncbi:9606">humans</span>
###xml 655 664 <span type="species:ncbi:5691">T. brucei</span>
###xml 1445 1451 <span type="species:ncbi:9606">humans</span>
Trypanosoma brucei is a parasitic protozoan of the family Trypanosomatidae (order Kinetoplastida, suborder Trypanosomatina) responsible for human African trypanosomiasis, also called sleeping sickness. The East and West African forms of the disease are caused by the T. b. rhodesiense and T. b. gambiense subspecies, respectively [1]. The disease is fatal if untreated, and the few available drugs are not ideal due to emerging drug resistance; parenteral administration; toxic side-effects and cost [2]. T. b. brucei, one of the causative agents of Nagana cattle disease, can serve as a model organism for drug discovery and is non-pathogenic to humans. T. brucei subspecies, along with all parasites of the order Kinetoplastida, possesses a novel thiol called trypanothione [N1, N8-bis(glutathionyl)spermidine] [3]. One of the major roles of this metabolite is to protect the parasite from oxidative stress by maintaining a reducing environment in the cell. In most other organisms, in particular mammals, it is glutathione that plays this protective role. Protection of the parasite against oxidative stress is achieved through the oxidation of the dithiol form of trypanothione (T(SH)2) into the disulphide form (T(S)2), followed by regeneration of T(SH)2 by the NADPH-dependent enzyme trypanothione reductase (TryR) (Fig. 1) [4]. A similar mechanism involving glutathione and glutathione reductase is observed in other organisms, including humans. However, the enzymes trypanothione reductase and glutathione reductase are highly specific for their respective disulphide substrates [5] such that selective inhibition by small molecules can be readily achieved [6].
###end p 8
###begin p 9
###xml 157 162 157 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib7 bib8 bib9" ref-type="bibr">[7&#8211;9]</xref>
###xml 177 189 177 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. b. brucei</italic>
###xml 240 250 240 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">inter alia</italic>
###xml 288 292 288 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib10" ref-type="bibr">[10]</xref>
###xml 341 353 341 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. b. brucei</italic>
###xml 401 409 401 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. cruzi</italic>
###xml 565 573 565 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. cruzi</italic>
###xml 627 639 627 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. b. brucei</italic>
###xml 669 677 669 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. cruzi</italic>
###xml 717 729 717 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. b. brucei</italic>
###xml 737 740 737 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib6" ref-type="bibr">[6]</xref>
###xml 950 962 950 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. b. brucei</italic>
###xml 1067 1082 1067 1082 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. b. gambiense</italic>
###xml 1138 1142 1138 1142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib11" ref-type="bibr">[11]</xref>
###xml 180 189 <span type="species:ncbi:497498">b. brucei</span>
###xml 344 353 <span type="species:ncbi:497498">b. brucei</span>
###xml 401 409 <span type="species:ncbi:5693">T. cruzi</span>
###xml 459 464 <span type="species:ncbi:9606">human</span>
###xml 565 573 <span type="species:ncbi:5693">T. cruzi</span>
###xml 630 639 <span type="species:ncbi:497498">b. brucei</span>
###xml 669 677 <span type="species:ncbi:5693">T. cruzi</span>
###xml 720 729 <span type="species:ncbi:497498">b. brucei</span>
###xml 953 962 <span type="species:ncbi:497498">b. brucei</span>
Metabolism of trypanothione and other low molecular weight thiols has been established as an attractive target for drug discovery in several trypanosomatids [7-9] and TryR from T. b. brucei has been specifically validated as a drug target, inter alia, by conditional knockout experiments [10]. However, kinetic and inhibition studies of the T. b. brucei enzyme have not been developed. Previously the T. cruzi enzyme has been used to guide drug discovery for human African trypanosomiasis (HAT), but absence of a clear correlation between inhibitor potency against T. cruzi TryR and cidal activity against bloodstream forms of T. b. brucei has raised concerns that the T. cruzi enzyme is not a suitable model for the T. b. brucei enzyme [6]. To address this issue, we report here a comprehensive comparative study of the physicochemical properties, structure, kinetics and inhibitor sensitivities of these enzymes. The information on the enzyme from T. b. brucei is also of particular relevance since it is identical at the amino acid level to the putative TryR from T. b. gambiense, the causative agent of over 90% of reported HAT cases [11].
###end p 9
###begin title 10
Materials and methods
###end title 10
###begin title 11
Organisms and reagents
###end title 11
###begin p 12
###xml 48 64 48 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 48 64 <span type="species:ncbi:562">Escherichia coli</span>
Routine plasmid manipulations were performed in Escherichia coli strain JM109 and over-expression in strain BL21 Star (DE3)pLysS (Invitrogen). All chemicals were of the highest grade available from Sigma, BDH and Molecular Probes. Restriction enzymes and DNA-modifying enzymes were from Promega or Roche.
###end p 12
###begin title 13
###xml 33 40 33 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 33 40 <span type="species:ncbi:562">E. coli</span>
Cloning and expression TbTryR in E. coli
###end title 13
###begin p 14
###xml 35 41 35 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TbTRYR</italic>
###xml 85 97 85 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. b. brucei</italic>
###xml 196 209 196 209 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tb10.406.0520</bold>
###xml 256 259 256 259 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAT</underline>
###xml 259 262 259 262 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATG</underline>
###xml 259 262 259 262 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>ATG</underline></bold>
###xml 299 306 299 306 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GGA TCC</underline>
###xml 306 309 306 309 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TTA</bold>
###xml 88 97 <span type="species:ncbi:497498">b. brucei</span>
The complete open reading frame of TbTRYR was amplified by PCR from genomic DNA from T. b. brucei strain S427 (MITat 1.4) using primers based on a putative TryR gene sequence deposited in GeneDB (Tb10.406.0520). The primers used for amplification were: 5'-CATATG TCC AAG GCC TTC GAT TTG G-3' and 5'-GGA TCCTTA CAG GTT AGA GTC CGG AAG C-3', incorporating the NdeI and BamHI restriction sites (underlined), respectively, with the start and stop codons in bold.
###end p 14
###begin p 15
###xml 204 206 192 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tb</italic>
###xml 256 258 244 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tb</italic>
###xml 379 380 360 361 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 433 434 413 414 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 692 693 660 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 693 696 661 664 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">600</sub>
###xml 733 734 686 687 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 893 894 846 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 997 998 944 945 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1001 1002 948 949 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1014 1015 961 962 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1017 1018 964 965 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
PCR amplification was done in triplicate. After sequencing, the PCR product of approximately1.49 kb was then cloned (via a TOPO cloning vector) into the NdeI/BamHI site of pET3a to generate plasmid pET3a-TbTryR. A 4 L culture of BL21 Star (DE3)pLysS/pET3a-TbTryR was grown to test expression and purification. The cells were grown at 37 degreesC in LB media, containing 50 mug ml1 carbenicillin for selection of pET3a and 12.5 mug ml1 chloramphenicol for the selection of pLysS, at 37 degreesC with moderate agitation (200 rpm). A larger scale expression in a 30 L culture was grown in a fermenter (Infors HT) using the same media and antibiotics at 37 degreesC. When the cultures reached an A600 of approximately0.6, isopropyl-beta-d-thiogalactopyranoside was added to a final concentration of 0.5 mM. Cultures were grown for an additional 16 h and then harvested by centrifugation at 3480 x g at 4 degreesC for 30 min and washed in phosphate buffered saline (137 mM NaCl, 2.68 mM KCl, 10.1 mM Na2HPO4, 1.76 mM KH2PO4).
###end p 15
###begin title 16
Purification of TbTryR
###end title 16
###begin p 17
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 110 112 110 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tb</italic>
###xml 299 303 299 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib12" ref-type="bibr">[12]</xref>
###xml 0 7 <span type="species:ncbi:562">E. coli</span>
E. coli cells were lysed using a one-shot cell disruptor (Constant Systems Ltd.). Purification of recombinant TbTryR was achieved by a combination of ammonium sulphate purification, affinity chromatography on 2'5'-ADP Sepharose, and anion exchange chromatography essentially as described previously [12]. Purity was assessed by SDS-PAGE.
###end p 17
###begin p 18
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tb</italic>
###xml 405 409 399 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib13" ref-type="bibr">[13]</xref>
###xml 370 376 <span type="species:ncbi:9913">bovine</span>
TbTryR was used directly from this procedure for crystallography, analysis of flavin content and measurement of extinction coefficient. The remainder of the TryR was precipitated with 70% saturating ammonium sulphate and aliquotted for storage at 4 degreesC for subsequent use in kinetic experiments. Protein concentration was measured using the method of Bradford with bovine serum albumin as a standard [13].
###end p 18
###begin title 19
Assessment of oligomeric state
###end title 19
###begin p 20
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tb</italic>
TbTryR (600 mug) was applied to a gel filtration column (Superdex 200 10/300 GE Healthcare) previously equilibrated with 25 mM HEPES pH 7.5 containing 100 mM NaCl. Elution of the column was monitored at 280 nm using an Akta purifier. Molecular weight was inferred from comparison with standards (BioRad gel filtration standard) on a plot of elution volume versus Log molecular weight. Samples of the recombinant enzyme were also analysed by analytical ultracentrifugation (Analytical ultracentrifugation service, College of Life Sciences, University of Dundee).
###end p 20
###begin title 21
Absorbance spectra and determination of absorption coefficient
###end title 21
###begin p 22
###xml 416 417 409 410 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 570 572 563 565 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 575 577 568 570 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 619 621 612 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tb</italic>
###xml 744 746 737 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tb</italic>
All spectra were carried out in a UV-1601pc temperature-regulated spectrophotometer (Shimadzu) using 1-cm path-length quartz cuvettes (200 mul sample volume). Enzymes were extensively dialysed against 40 mM HEPES pH 7.4, 1 mM EDTA. Absorbance spectra were acquired over a range of 200-800 nm. The enzyme-associated flavin was liberated by thermal denaturation at 100 degreesC for 20 min in the presence of 10 mM MgCl2. Denatured protein was removed by microcentrifugation and the concentration of free flavin determined from its absorption coefficient at 450 nm (11.3 mM-1 cm-1). The absorption coefficient of oxidised TbTryR was calculated from the absorbance at 463 nm/[FAD] in triplicate samples. The absorption coefficient of NADPH-reduced TbTryR at 530 nM was calculated from the absorbance at 530 nm/[FAD].
###end p 22
###begin title 23
Enzyme assays
###end title 23
###begin p 24
###xml 118 122 118 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib14" ref-type="bibr">[14]</xref>
###xml 206 212 206 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 215 219 215 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib15" ref-type="bibr">[15]</xref>
###xml 478 480 459 461 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 517 518 496 497 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 815 817 781 783 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 849 850 813 814 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 917 918 880 881 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1212 1213 1175 1176 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 1215 1217 1178 1180 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 1220 1222 1183 1185 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 1222 1226 1185 1189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib16" ref-type="bibr">[16]</xref>
###xml 1253 1254 1216 1217 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
TryR was assayed spectrophotometrically either by monitoring the trypanothione-dependent oxidation of NADPH at 340 nm [14], or by the reduction of 5,5'-dithio-bis(2-nitrobenzoic acid) (DTNB) at 412 nm (see Fig. 1B) [15]. Assays at 340 nm were carried out at 25 degreesC in 500 mul volume acrylic cuvettes and changes in absorbance monitored with a UV-1601 PC spectrophotometer (Shimadzu). The standard assay mixture contained 40 mM HEPES pH 7.4, 1 mM EDTA, approximately10 mU ml-1 TryR, 150 muM NADPH and 100 muM T(S)2. Assays at 412 nm were carried out in 96-well plates (Polysorp, Nunc) at room temperature in a volume of 200 mul. Changes in absorbance were monitored in a SpectraMax 340pc plate reader (Molecular Devices). The standard assay mixture contained 40 mM HEPES pH 7.4, 1 mM EDTA, approximately10 mU ml-1 TryR, 150 muM NADPH, 6 muM T(S)2 and 50 muM DTNB. All assays were initiated by addition of the T(S)2. Data was collected using SoftMax Pro (molecular devices) and UVProbe 2 (Shimadzu) software, processed and analysed using Excel 2002 (Microsoft) and GraFit 5 (Erithacus Software). NADPH stock solutions were measured spectrophotometrically at 340 nm using an absorption coefficient of 6.22 x 103 M-1 cm-1[16]. The concentration of T(S)2 stock solutions were determined by measuring the oxidation of NADPH in the presence of excess TryR.
###end p 24
###begin title 25
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 1 2 1 2 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
Km analyses
###end title 25
###begin p 26
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 1 2 1 2 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 30 31 30 31 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 52 54 52 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tb</italic>
###xml 101 109 101 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. cruzi</italic>
###xml 130 134 130 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib12" ref-type="bibr">[12]</xref>
###xml 253 254 253 254 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 289 290 289 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 290 291 290 291 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 301 302 301 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 302 303 302 303 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 101 109 <span type="species:ncbi:5693">T. cruzi</span>
Km values with respect to T(S)2 were determined for TbTryR in both assays using purified recombinant T. cruzi TryR for comparison [12]. Determinations for each enzyme were carried out in three independent experiments and a weighted mean calculated. T(S)2 concentration was varied from 5 x Km to 0.5 x Km.
###end p 26
###begin p 27
###xml 297 298 294 295 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Substrate specificity in the 412 nm DTNB-coupled assay was investigated by comparing the reaction velocity in the standard assay mixture with reactions where 150 muM NADH was substituted for the NADPH and by comparing velocities of reactions containing 50 muM glutathione disulphide or 50 muM T(S)2. Values are presented as the mean and standard deviation of four replicates.
###end p 27
###begin p 28
###xml 22 23 22 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 23 24 23 24 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 183 207 183 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 207 211 207 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib17" ref-type="bibr">[17]</xref>
###xml 314 316 313 315 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 421 423 420 422 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 467 468 466 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 468 469 467 468 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 579 581 566 568 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 598 599 584 585 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 717 718 701 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 718 719 702 703 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 769 771 753 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tb</italic>
###xml 183 207 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
In order to determine Km with respect to NADPH using the 412 nm DTNB assay, NADPH levels were maintained constant using glucose-6-phosphate and glucose-6-phosphate dehydrogenase from Saccharomyces cerevisiae[17]. Preliminary experiments over a range of NADPH concentrations (0.5-150 muM) established that 200 mU ml-1 of glucose-6-phosphate dehydrogenase was non-limiting (plateaux region of reaction velocity versus mU ml-1) and therefore chosen for determination of Km with respect to NADPH. The final assay mixture contained 40 mM HEPES pH 7.4, 1 mM EDTA, approximately10 mU ml-1 TryR, 6 muM T(S)2, 50 muM DTNB and 0.2-200 muM NADPH (7-point 3-fold serial dilution). Assays were initiated by addition of the NADPH. Km values with respect to NADPH were determined for TbTryR in three independent experiments and a weighted mean calculated.
###end p 28
###begin title 29
Enzyme inhibition studies
###end title 29
###begin p 30
###xml 50 52 50 52 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 149 150 149 150 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 160 161 160 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 161 162 161 162 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 749 750 747 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Z</italic>
###xml 821 825 819 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib18" ref-type="bibr">[18]</xref>
Inhibitor concentrations giving 50% inhibition (IC50) were determined using the 412 nm assay with the standard assay mixture modified to contain T(S)2 at [S] = Km. Assay plates were prepared using a Precision2000 liquid handler (Bio-Tek) with a final DMSO concentration of 1% in all wells. Plates contained a 10-point serial dilution (2-fold or 3-fold dilutions) across columns 2-11 with a top concentration of 100 muM or 200 muM. Seven compounds were tested per plate in rows A-G, row H was used for a clomipramine control on each plate. Column 1 contained full signal controls (no inhibitor) and column 12 contained background controls (no enzyme). All compounds were tested on three separate occasions and the results reported as weighted means. Z' figures were calculated from the full signal and background controls [18].
###end p 30
###begin title 31
Assessment of mode of inhibition
###end title 31
###begin p 32
###xml 67 68 67 68 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 311 312 306 307 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 477 478 469 470 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 580 582 569 571 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 608 609 596 597 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 939 940 927 928 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">y</italic>
Clomipramine was tested for mode of inhibition with respect to T(S)2. The standard 412 nm DTNB-coupled assay was used with the following modifications. Aliquots of the assay mixture (180 mul) containing 0 muM, 1 muM, 2 muM and 4 muM clomipramine were added to four rows of a microtitre plate, respectively. T(S)2 was serially diluted across a fifth row of the plate to produce a 12-point range from 500 muM to 5.8 muM. The assay was initiated by transferring 20 mul of the T(S)2 row to each of the assay rows. The final 200 mul assay contained 150 muM NADPH, 50 muM DTNB, 10 mU ml-1 TryR and 50-0.58 muM T(S)2. The rate of reaction was measured as before. Each data set was fitted by non-linear regression to the Michaelis-Menten equation using GraFit 5.0 (Erithacus software). The resulting individual fits were examined as Lineweaver-Burke transformations and the graphs inspected to confirm competitive inhibition mode (intersection on y-axis). The entire data set was then globally fitted to the competitive-mode equation.
###end p 32
###begin title 33
Growth inhibition studies
###end title 33
###begin p 34
###xml 74 76 74 76 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 117 124 117 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib19 bib20" ref-type="bibr">[19,20]</xref>
###xml 143 155 143 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. b. brucei</italic>
###xml 227 228 221 222 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 248 252 242 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib21" ref-type="bibr">[21]</xref>
###xml 772 773 765 766 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 776 778 769 771 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 1013 1015 1005 1007 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 146 155 <span type="species:ncbi:497498">b. brucei</span>
The effective concentration of compounds inhibiting cell growth by 50% (EC50) was determined as previously described [19,20]. Bloodstream form T. b. brucei cells (strain 427, 'single marker') were grown at 37 degreesC and 5% CO2 in a modified HMI9 [21] (HMI9-T where 0.2 mM 2-mercaptoethanol was replaced with 0.056 mM thioglycerol). Stock cultures were maintained in T75 vented cap culture flasks (Greiner, Kremsmuenster, Austria) and sub-cultured every 48-72 h by dilution into fresh medium. For microtitre plate assays, cells were counted using a Casy cell counter TT (Scharfe systems) and diluted appropriately. Compounds were tested in 96-well test plates (Greiner). The final conditions were 50-0.07 muM test compound (9-point 3-fold serial dilutions), 0.5% DMSO, 103 ml-1 cells in a total volume of 0.2 ml. Plates were incubated for 3 days, resazurin was added to a final concentration of 45 muM and plates incubated for a further 4 h. Fluorescence was measured at 528 nm excitation and 590 nm emission. EC50 values were determined in three separate experiments and the data reported as weighted means.
###end p 34
###begin title 35
Crystallography
###end title 35
###begin p 36
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tb</italic>
###xml 34 36 34 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 783 787 775 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib22" ref-type="bibr">[22]</xref>
###xml 807 811 799 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib23" ref-type="bibr">[23]</xref>
###xml 848 850 840 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tc</italic>
###xml 865 872 857 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib18 bib24" ref-type="bibr">[18,24]</xref>
###xml 916 918 908 910 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tb</italic>
###xml 981 985 973 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib25" ref-type="bibr">[25]</xref>
###xml 1028 1032 1020 1024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib26" ref-type="bibr">[26]</xref>
###xml 1071 1078 1063 1070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib27 bib28" ref-type="bibr">[27,28]</xref>
TbTryR was concentrated to 12.4 mg-1 ml in 20 mM bis-Tris buffer pH 7.0 containing 95 mM KCl, 1 mM EDTA and 1 mM DTT. The protein was crystallised by the hanging drop vapour-diffusion method at 20 degreesC using 24-well VDX plates with 500 mul of reservoir solution. Crystals were cryoprotected by sequential immersion for 5 s into a 3-mul drop containing 0.1 M bis-Tris propane pH 8.0, 5% PEG 400, 1 M ammonium sulphate plus 10% glycerol, then the same solution plus 20% glycerol and finally into another drop with 30% glycerol before flash-freezing them in liquid nitrogen. High resolution X-ray data to 2.3 A was collected at with a MicroMax-007HF X-ray generator (Rigaku) and an R-axis IV detector (Rigaku) at a wavelength of 1.5428 A. The X-ray data was integrated using MOSFLM [22], scaled with SCALA [23], and the structure solved using the TcTryR structure [18,24], which shares 84% sequence similarity with TbTryR, as the input model for molecular replacement with MOLREP [25]. Model building was carried out with COOT [26] and structure refinement with REFMAC5 [27,28].
###end p 36
###begin title 37
Results and discussion
###end title 37
###begin title 38
Cloning and expression
###end title 38
###begin p 39
###xml 39 51 39 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. b. brucei</italic>
###xml 327 342 327 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. b. gambiense</italic>
###xml 42 51 <span type="species:ncbi:497498">b. brucei</span>
The gene encoding TryR was cloned from T. b. brucei strain 427 and found to be identical with that from the genome sequencing strain 927, apart from nucleotide substitutions of C for T at position 105 and A for G at position 906. Nevertheless, the two sequences are identical at the amino acid level. As noted above, TryR from T. b. gambiense is also identical at the amino acid level.
###end p 39
###begin p 40
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tb</italic>
###xml 41 48 41 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 130 136 130 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 141 148 141 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl1" ref-type="table">Table 1</xref>
###xml 204 206 204 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 231 239 231 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. cruzi</italic>
###xml 249 251 249 251 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 253 257 253 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib12" ref-type="bibr">[12]</xref>
###xml 262 273 262 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 283 285 283 285 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 287 291 287 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib29" ref-type="bibr">[29]</xref>
###xml 322 324 322 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 343 351 343 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. cruzi</italic>
###xml 369 371 369 371 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 373 377 373 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib12" ref-type="bibr">[12]</xref>
###xml 382 395 382 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. congolense</italic>
###xml 405 407 405 407 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 409 413 409 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib30" ref-type="bibr">[30]</xref>
###xml 481 483 481 483 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 41 48 <span type="species:ncbi:562">E. coli</span>
###xml 231 239 <span type="species:ncbi:5693">T. cruzi</span>
###xml 262 273 <span type="species:ncbi:5661">L. donovani</span>
###xml 343 351 <span type="species:ncbi:5693">T. cruzi</span>
###xml 382 395 <span type="species:ncbi:5692">T. congolense</span>
TbTryR was expressed in a 4 L culture of E. coli strain BL21 Star(DE3)pLysS competent cells and purified to apparent homogeneity (Fig. 2 and Table 1). The specific activity of the purified enzyme (91 U mg-1) is similar that of the T. cruzi (143 U mg-1) [12] and L. donovani (113 U mg-1) [29]. The overall yield of 7.6 mg l-1 is similar to the T. cruzi enzyme (19.0 mg l-1) [12] and T. congolense (3.2 mg l-1) [30]. Scaling up expression in a 30 L fermenter culture yielded 8.8 mg l-1 TbTryR.
###end p 40
###begin title 41
Analysis of oligomeric state
###end title 41
###begin p 42
###xml 20 22 20 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tb</italic>
The subunit mass of TbTryR was calculated as 53,156 Da. Gel filtration revealed 86% of the sample eluting at a volume corresponding to 96 kDa (data not shown). Analytical ultracentrifugation indicated 90% of the sample was present at a molecular weight of approximately 93 kDa (data not shown). Both techniques therefore indicated the protein was almost entirely present as a dimer in solution.
###end p 42
###begin title 43
Spectroscopic analysis
###end title 43
###begin p 44
###xml 12 14 12 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tb</italic>
###xml 109 116 109 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl2" ref-type="table">Table 2</xref>
###xml 121 127 121 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 129 136 129 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib31 bib32" ref-type="bibr">[31,32]</xref>
###xml 159 165 159 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 412 416 412 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib32" ref-type="bibr">[32]</xref>
###xml 548 550 546 548 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 553 555 551 553 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 567 568 565 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 607 613 605 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 939 943 937 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib29" ref-type="bibr">[29]</xref>
Recombinant TbTryR possesses spectral properties closely resembling those of other trypanothione reductases (Table 2 and Fig. 3) [31,32]. The oxidised enzyme (Fig. 3 solid line), where the redox-active cysteine residues, Cys52 and Cys57, within the disulphide binding site are covalently linked in a disulphide bridge, exhibits maxima at 273, 378 and 463 nm and a shoulder at 486 nm indicative of a flavoprotein [32]. Thermal liberation of the flavin prosthetic group yielded a mean absorption coefficient for the oxidised enzyme of 11.4 +/- 0.3 mM-1 cm-1 at 463 nm (n = 4). Addition of excess NADPH (2 mM, Fig. 3 dotted line), leads to a decrease in the absorbance at 463 nm with concomitant acquisition of a broad long-wavelength absorption band at 530 nm due to reduction of the cysteine disulphide bridge and accompanying formation of a characteristic charge transfer complex between the FAD and the proximal sulphydryl group of Cys57 [29]. This spectrum is stable indefinitely in the presence of excess NADPH.
###end p 44
###begin title 45
Substrate analysis
###end title 45
###begin p 46
###xml 4 5 4 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 5 6 5 6 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 22 23 22 23 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 99 107 99 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. cruzi</italic>
###xml 114 121 114 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl2" ref-type="table">Table 2</xref>
###xml 128 129 128 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 129 130 129 130 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 146 154 146 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. cruzi</italic>
###xml 99 107 <span type="species:ncbi:5693">T. cruzi</span>
###xml 146 154 <span type="species:ncbi:5693">T. cruzi</span>
The Km values for T(S)2 with saturating NADPH in both the 340 and 412 nm assays were compared with T. cruzi TryR (Table 2). The Km values for the T. cruzi enzyme were 4.3- and 4.4-fold greater in each assay, respectively.
###end p 46
###begin p 47
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tb</italic>
###xml 85 86 85 86 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 288 289 284 285 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
TbTryR was highly specific for the electron donor (NADPH) and electron acceptor (T(S)2) in the 412 nm assay. Activity with 150 muM NADH was only 5.7% of that obtained with 150 muM NADPH and the rate of reduction of 50 muM glutathione disulphide was 0.03% of that obtained with 50 muM T(S)2.
###end p 47
###begin p 48
###xml 39 40 39 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 40 41 40 41 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 377 383 377 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 400 401 400 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 401 402 401 402 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
We were unable to reliably determine a Km with respect to NADPH in either the 340 nm direct assay or the 412 nm DTNB-coupled assay due to the short periods of linearity at low NADPH concentrations. Hence we developed a modified 412 nm DTNB-coupled assay wherein the NADPH level was maintained constant by inclusion of glucose-6-phosphate and glucose-6-phosphate dehydrogenase (Fig. 1C). The apparent Km for NADPH determined in this modified assay was 0.77 muM.
###end p 48
###begin p 49
###xml 26 27 26 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 27 30 27 30 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cat</sub>
###xml 31 32 31 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 32 33 32 33 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 43 55 43 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. b. brucei</italic>
###xml 72 73 72 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 75 77 75 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 79 81 79 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 143 151 143 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. cruzi</italic>
###xml 161 162 161 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 164 166 164 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 167 169 167 169 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 171 178 171 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib12 bib31" ref-type="bibr">[12,31]</xref>
###xml 183 194 183 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 204 205 204 205 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 207 209 207 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 211 213 211 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 215 219 215 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib29" ref-type="bibr">[29]</xref>
###xml 268 276 268 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. cruzi</italic>
###xml 286 287 286 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 289 291 289 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 293 295 293 295 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 297 304 297 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl2" ref-type="table">Table 2</xref>
###xml 46 55 <span type="species:ncbi:497498">b. brucei</span>
###xml 143 151 <span type="species:ncbi:5693">T. cruzi</span>
###xml 183 194 <span type="species:ncbi:5661">L. donovani</span>
###xml 268 276 <span type="species:ncbi:5693">T. cruzi</span>
The specificity constant (kcat/Km) for the T. b. brucei enzyme (8.7 x 106 M-1 s-1) compares favourably with the previously reported values for T. cruzi (5.2 x 106 M-1 -1) [12,31] and L. donovani (5.0 x 106 M-1 s-1) [29]. (Note that the lower value determined here for T. cruzi (2.6 x 106 M-1 s-1; Table 2) is due to loss of approximately50% activity on prolonged storage at 4 degreesC as an ammonium sulphate suspension.)
###end p 49
###begin title 50
Inhibitor testing
###end title 50
###begin p 51
###xml 95 107 95 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. b. brucei</italic>
###xml 112 120 112 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. cruzi</italic>
###xml 234 236 234 236 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 276 277 276 277 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 324 325 324 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 325 326 325 326 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 437 444 437 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl3" ref-type="table">Table 3</xref>
###xml 449 455 449 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">Fig. 4</xref>
###xml 534 535 534 535 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 585 586 585 586 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 630 636 630 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 643 644 643 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 644 645 644 645 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 785 786 782 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 786 787 783 784 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 816 818 812 814 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 871 872 867 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 872 873 868 869 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 877 879 873 875 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 886 887 882 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 887 888 883 884 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 98 107 <span type="species:ncbi:497498">b. brucei</span>
###xml 112 120 <span type="species:ncbi:5693">T. cruzi</span>
In order to identify potential differences in the sensitivity of trypanothione reductases from T. b. brucei and T. cruzi to small-molecule inhibitors, ten compounds spanning a range of inhibitor chemotypes, were tested for potency (IC50 values) against the two enzymes at T(S)2 concentrations equivalent to their respective Km values. With these ten inhibitors the maximum difference between sensitivity of the two enzymes was 3.3-fold (Table 3 and Fig. 4). The mode of inhibition by clomipramine was confirmed as competitive for T(S)2 by measuring reaction velocity while varying T(S)2 at a range of clomipramine concentrations (Fig. 5). The Ki value from three independent experiments yielded a mean weighted to standard error of 3.03 +/- 0.28 muM. This is similar to the calculated Ki value of 5.5 muM from our IC50 determination (for a competitive inhibitor at [S] = Km, IC50 = 2 x Km).
###end p 51
###begin p 52
###xml 106 114 106 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 124 136 124 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. b. brucei</italic>
###xml 151 158 151 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib19 bib33" ref-type="bibr">[19,33]</xref>
###xml 231 233 231 233 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 363 370 363 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl3" ref-type="table">Table 3</xref>
###xml 392 394 392 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tb</italic>
###xml 411 413 411 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tc</italic>
###xml 443 446 443 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib6" ref-type="bibr">[6]</xref>
###xml 534 535 534 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 535 536 535 536 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 127 136 <span type="species:ncbi:497498">b. brucei</span>
Ebselen, clomipramine and the four compounds DM5a; DM6a; DM7a and DM8a were known to be active against an in vitro assay of T. b. brucei proliferation [19,33]. Under identical conditions, the concentration inhibiting 50% growth (EC50) was determined here for three of the remaining TryR inhibitors, all of which were active in the single-figure micromolar range (Table 3). Despite the use of TbTryR in place of TcTryR used in previous studies [6], correlation between TryR inhibition and trypanocidal activity remains modest at best (r2 = 0.49). This indicates either significant differences in the uptake of these compounds or, more likely, that some of these compounds inhibit other targets within the cell.
###end p 52
###begin p 53
###xml 196 200 196 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib34" ref-type="bibr">[34]</xref>
###xml 298 300 298 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tc</italic>
###xml 305 312 305 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib35 bib36" ref-type="bibr">[35,36]</xref>
###xml 380 388 380 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 412 414 412 414 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 451 453 451 453 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 528 532 528 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib37" ref-type="bibr">[37]</xref>
###xml 559 561 559 561 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 771 778 771 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 800 807 800 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 91 96 <span type="species:ncbi:9606">human</span>
###xml 489 494 <span type="species:ncbi:10090">mouse</span>
###xml 629 634 <span type="species:ncbi:10090">mouse</span>
Several of the compounds used in our study are currently in clinical use or have undergone human clinical trials; for example ebselen is being evaluated for the treatment of acute ischemic stroke [34]. Thioridazine, trifluoperazine and clomipramine have been previously identified as inhibitors of TcTryR [35,36]. Although these CNS-active drugs show potent trypanocidal activity in vitro, thioridazine (50 mg kg-1, i.p.) and trifluoperazine (50 mg kg-1, i.p.) are inactive in the chronic mouse model of African trypanosomiasis [37] and clomipramine (50 mg kg-1, i.p.) failed to extend survival time by even one day in the acute mouse model (Halliburton and Fairlamb, unpublished). To our knowledge the structurally distinct antidepressant citalopram has not been tested in vivo. Despite the lack of in vivo activity, these molecules represent useful potential starting points for drug development for HAT, particularly as they are likely to cross the blood-brain barrier and therefore could be active against the late stage of the disease.
###end p 53
###begin title 54
Crystallography
###end title 54
###begin p 55
###xml 335 337 333 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tc</italic>
###xml 389 391 387 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tb</italic>
###xml 415 422 413 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl4" ref-type="table">Table 4</xref>
###xml 424 426 422 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tb</italic>
###xml 984 986 982 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tb</italic>
###xml 992 998 990 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig6" ref-type="fig">Fig. 6</xref>
###xml 1032 1034 1030 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tc</italic>
###xml 1178 1180 1172 1174 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2,</sub>
###xml 1286 1290 1280 1284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib24" ref-type="bibr">[24]</xref>
###xml 1330 1336 1324 1330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig6" ref-type="fig">Fig. 6</xref>
Large crystals (approximately 0.8 mm x 0.3 mm x 0.05 mm) diffracting to 2.3 A were obtained in drops containing 2.0 mul of protein solution plus 1.0 mul reservoir solution, where the reservoir consisted of 0.1 M bis-Tris propane pH 8.0, 5% PEG 400, 2 M ammonium sulphate. Diffraction data was solved by molecular replacement using the TcTryR structure; the overall statistics of the final TbTryR model are given in Table 4. TbTryR is a homodimer and each subunit of the final model comprises 489 amino acid residues, 1 FAD, 1 NADPH, 4 glycerol and 1 sulphate molecules. Also present are 786 solvent positions that were modelled as oxygen atoms and 1 PEG400 molecule (associated with subunit A). The first residue and the last 2 residues in both subunits were excluded from the structure as there was no convincing electron density to model. The same applies to the nicotinamide moieties of the two NADPH molecules, which were not included in the final model. The overall structure of TbTryR (Fig. 6A) is nearly identical to that of TcTryR (rmsd = 0.6 A over 482 Calpha atoms). All the catalytically important residues (Cys52, Cys57 and His461) and residues interacting with T(S)2, including those involved in binding the spermidine moiety (Leu17, Glu18, Trp21, Met 113, Ser109, Tyr110) [24] are conserved between both structures (Fig. 6B).
###end p 55
###begin title 56
Conclusion
###end title 56
###begin p 57
###xml 54 56 54 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tb</italic>
###xml 141 149 141 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. cruzi</italic>
###xml 154 165 154 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 210 211 210 211 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 297 299 297 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tb</italic>
###xml 308 310 308 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tc</italic>
###xml 327 328 327 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 328 329 328 329 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 483 495 483 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib6 bib19 bib33 bib38" ref-type="bibr">[6,19,33,38]</xref>
###xml 658 662 658 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib39" ref-type="bibr">[39]</xref>
###xml 900 901 900 901 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1082 1083 1082 1083 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1140 1141 1140 1141 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1203 1204 1203 1204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 1204 1205 1204 1205 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 1233 1240 1221 1228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib33 bib40" ref-type="bibr">[33,40]</xref>
###xml 1281 1282 1269 1270 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1323 1324 1311 1312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 1324 1325 1312 1313 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 1426 1427 1402 1403 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 141 149 <span type="species:ncbi:5693">T. cruzi</span>
###xml 154 165 <span type="species:ncbi:5661">L. donovani</span>
###xml 578 583 <span type="species:ncbi:9606">human</span>
In conclusion, the kinetic and physical properties of TbTryR are consistent with trypanothione reductases from other trypanosomatids such as T. cruzi and L. donovani, especially the striking preference for T(S)2 over glutathione disulphide. We have observed no significant differences between the TbTryR and TcTryR in terms of Km, sensitivity to inhibitors or in crystal structure. Thus, either enzyme may be used as an effective surrogate for the other in high-throughput screening [6,19,33,38] and structure-based inhibitor design as part of a drug discovery campaign against human African trypanosomiasis or Chagas' disease. One of Lipinski's "Rule of 5" [39] states that, for an orally bioavailable drug, the molecular mass should ideally be under 500 Da. Thus, one major challenge with druggability of this target is the large size of the active site, which must accommodate the substrates, T(S)2 (721 Da) or glutathionylspermidine disulphide (867 Da). In addition, a second challenge is the potential for displacement of reversible inhibitors from TryR by accumulation of T(S)2 as a consequence of further cellular metabolism of T[SH]2. Although we have now identified competitive inhibitors with Ki values approximately250 nM [33,40], theoretical calculations based on T[SH]2 concentrations in the cell suggest that Ki values approximately1-10 nM are required to sustain >90% inhibition in the face of accumulating T[S]2. Alternatively, irreversible active site directed inhibitors are required. Either strategy would be greatly enhanced with knowledge of the binding mode of inhibitors in the active site pocket of the enzyme. Details will be reported in subsequent publications.
###end p 57
###begin title 58
Acknowledgments
###end title 58
###begin p 59
The authors wish to acknowledge Dr Ahilan Saravanamuthu for preliminary studies and Dr Tim Vickers for helpful discussions.
###end p 59
###begin p 60
This work was supported by the Wellcome Trust (WT079838 and WT083481) and the Drugs for Neglected Diseases initiative.
###end p 60
###begin p 61
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Note:</italic>
Note: Crystallographic data have been deposited on PDB with the accession code 2wba.
###end p 61
###begin title 62
References
###end title 62
###begin article-title 63
Kinetoplastids: related protozoan pathogens, different diseases
###end article-title 63
###begin article-title 64
Drug discovery and development for neglected parasitic diseases
###end article-title 64
###begin article-title 65
Trypanothione: a novel bis(glutathionyl)spermidine cofactor for glutathione reductase in trypanosomatids
###end article-title 65
###begin article-title 66
Metabolism and functions of trypanothione in the Kinetoplastida
###end article-title 66
###begin article-title 67
###xml 81 102 <span type="species:ncbi:5656">Crithidia fasciculata</span>
Substrate specificity of the flavoprotein trypanothione disulfide reductase from Crithidia fasciculata
###end article-title 67
###begin article-title 68
Discovery of 2-iminobenzimidazoles as a new class of trypanothione reductase inhibitor by high-throughput screening
###end article-title 68
###begin article-title 69
The therapeutic potential of inhibitors of the trypanothione cycle
###end article-title 69
###begin article-title 70
Trypanothione as a target in the design of antitrypanosomal and antileishmanial agents
###end article-title 70
###begin article-title 71
Thiol metabolism of the trypanosomatids as potential drug targets
###end article-title 71
###begin article-title 72
Trypanosomes lacking trypanothione reductase are avirulent and show increased sensitivity to oxidative stress
###end article-title 72
###begin article-title 73
###xml 12 17 <span type="species:ncbi:9606">human</span>
Eliminating human African trypanosomiasis: where do we stand and what comes next?
###end article-title 73
###begin article-title 74
###xml 59 76 <span type="species:ncbi:5693">Trypanosoma cruzi</span>
Site-directed mutagenesis of the redox-active cysteines of Trypanosoma cruzi trypanothione reductase
###end article-title 74
###begin article-title 75
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
###end article-title 75
###begin article-title 76
###xml 29 46 <span type="species:ncbi:5693">Trypanosoma cruzi</span>
Trypanothione reductase from Trypanosoma cruzi: catalytic properties of the enzyme and inhibition studies with trypanocidal compounds
###end article-title 76
###begin article-title 77
Ellman's-reagent-mediated regeneration of trypanothione in situ: substrate-economical microplate and time-dependent inhibition assays for trypanothione reductase
###end article-title 77
###begin article-title 78
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast glutathione reductase. Steady-state kinetic studies of its transhydrogenase activity
###end article-title 78
###begin article-title 79
Cycling of NADPH by glucose 6-phosphate dehydrogenase optimizes the spectrophotometric assay of nitric oxide synthase activity in cell lysates
###end article-title 79
###begin article-title 80
A simple statistical parameter for use in evaluation and validation of high throughput screening assays
###end article-title 80
###begin article-title 81
High-throughput screening affords novel and selective trypanothione reductase inhibitors with anti-trypanosomal activity
###end article-title 81
###begin article-title 82
The Alamar Blue(R) assay to determine drug sensitivity of African trypanosomes (T. b. rhodesiense and T. b. gambiense) in vitro
###end article-title 82
###begin article-title 83
###xml 26 44 <span type="species:ncbi:5691">Trypanosoma brucei</span>
Continuous cultivation of Trypanosoma brucei blood stream forms in a medium containing a low concentration of serum protein without feeder cell layers
###end article-title 83
###begin article-title 84
Evaluation of single-crystal X-ray-diffraction data from a position-sensitive detector
###end article-title 84
###begin article-title 85
###xml 58 63 <span type="species:ncbi:9606">human</span>
###xml 73 90 <span type="species:ncbi:5693">Trypanosoma cruzi</span>
The crystal structure of trypanothione reductase from the human pathogen Trypanosoma cruzi at 2.3A resolution
###end article-title 85
###begin article-title 86
MOLREP: an automated program for molecular replacement
###end article-title 86
###begin article-title 87
Coot: model-building tools for molecular graphics
###end article-title 87
###begin article-title 88
Refinement of macromolecular structures by the maximum-likelihood method
###end article-title 88
###begin article-title 89
The CCP4 suite: programs for protein crystallography
###end article-title 89
###begin article-title 90
###xml 29 48 <span type="species:ncbi:5661">Leishmania donovani</span>
Trypanothione reductase from Leishmania donovani-purification, characterisation and inhibition by trivalent antimonials
###end article-title 90
###begin article-title 91
###xml 14 36 <span type="species:ncbi:5692">Trypanosoma congolense</span>
###xml 64 80 <span type="species:ncbi:562">Escherichia coli</span>
Expression of Trypanosoma congolense trypanothione reductase in Escherichia coli: overproduction, purification, and characterization
###end article-title 91
###begin article-title 92
###xml 29 46 <span type="species:ncbi:5693">Trypanosoma cruzi</span>
Trypanothione reductase from Trypanosoma cruzi: purification and characterization of the crystalline enzyme
###end article-title 92
###begin article-title 93
###xml 66 87 <span type="species:ncbi:5656">Crithidia fasciculata</span>
Purification and characterization of trypanothione reductase from Crithidia fasciculata, a newly discovered member of the family of disulphide-containing flavoprotein reductases
###end article-title 93
###begin article-title 94
Improved tricyclic inhibitors of trypanothione reductase by screening and chemical synthesis
###end article-title 94
###begin article-title 95
Ebselen in acute ischemic stroke-a placebo-controlled, double-blind clinical trial
###end article-title 95
###begin article-title 96
###xml 0 17 <span type="species:ncbi:5693">Trypanosoma cruzi</span>
Trypanosoma cruzi trypanothione reductase inhibitors: phenothiazines and related compounds modify experimental Chagas' disease evolution
###end article-title 96
###begin article-title 97
Rationally designed selective inhibitors of trypanothione reductase: phenothiazines and related tricyclics as lead structures
###end article-title 97
###begin article-title 98
###xml 18 24 <span type="species:ncbi:10090">murine</span>
Phenothiazines in murine African trypanosomiasis
###end article-title 98
###begin article-title 99
Trypanothione reductase high-throughput screening campaign identifies novel classes of inhibitors with anti-parasitic activity
###end article-title 99
###begin article-title 100
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
###end article-title 100
###begin article-title 101
Synthesis and evaluation of 1-(1-(benzo[b]thiophen-2-yl)cyclohexyl)piperidine (BTCP) analogues as inhibitors of trypanothione reductase
###end article-title 101
###begin p 102
###xml 245 246 245 246 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-</sup>
Trypanothione reductase assay principle. Panel A, structure of trypanothione disulphide. Panel B, in the DTNB-coupled assay trypanothione is recycled to trypanothione disulphide by the reduction of DTNB. Formation of thionitrobenzoate anion (TNB-) is monitored at 412 nm. Panel C, in a modification of the DTNB-coupled assay NADPH is recycled by the enzyme glucose-6-phosphate dehydrogenase.
###end p 102
###begin p 103
###xml 277 285 273 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. cruzi</italic>
###xml 277 285 <span type="species:ncbi:5693">T. cruzi</span>
Analysis of trypanothione reductase purification by SDS-PAGE. Lane 1, crude cell lysate (2 mug); lane 2, protein after 35-70% ammonium sulphate cut (2 mug); lane 3, eluate from 2'5'-ADP Sepharose column (1 mug); lane 4, eluate from Q-Sepharose column (1 mug); lane 5, purified T. cruzi recombinant trypanothione reductase (0.2 mug).
###end p 103
###begin p 104
###xml 31 37 31 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TbTryR</italic>
Absorption spectra of purified TbTryR. Solid line, oxidised enzyme; dashed line, 30 min after addition 2 mM NADPH.
###end p 104
###begin p 105
###xml 40 42 40 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tb</italic>
###xml 51 53 51 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tc</italic>
###xml 129 131 129 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tb</italic>
###xml 140 142 140 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tc</italic>
###xml 152 159 152 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl3" ref-type="table">Table 3</xref>
Structures of inhibitors tested against TbTryR and TcTryR. The following compounds were tested for potency of inhibition against TbTryR and TcTryR, see Table 3.
###end p 105
###begin p 106
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 1 2 1 2 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 20 22 20 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tb</italic>
###xml 61 62 61 62 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 146 147 146 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 147 148 147 148 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 159 160 159 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
Ki determination of TbTryR with respect to clomipramine. T(S)2 was varied as the substrate to confirm the mode of clomipramine inhibition and the Ki value. An F-test confirmed the mode of inhibition as linear competitive. Clomipramine was added at 0 muM (open circles); 1 muM (closed circles); 2 muM (open squares) and 4 muM (closed squares).
###end p 106
###begin p 107
###xml 21 23 21 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tb</italic>
###xml 195 197 195 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tb</italic>
###xml 256 258 256 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tc</italic>
###xml 362 364 362 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tc</italic>
Crystal structure of TbTryR. Panel A, the crystal structure is coloured to differentiate the two subunits forming the homodimer. FAD is shown in red and NADPH in blue. Panel B, a close-up of the TbTryR active site (purple and yellow) superimposed onto the TcTryR active site (black and grey, pdb code  ). Trypanothione is shown bound into the active site of the TcTryR structure.
###end p 107
###begin p 108
###xml 28 40 28 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. b. brucei</italic>
###xml 70 77 70 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 31 40 <span type="species:ncbi:497498">b. brucei</span>
###xml 70 77 <span type="species:ncbi:562">E. coli</span>
Purification of recombinant T. b. brucei trypanothione reductase from E. coli. Activity was measured in the standard 340 nm assay as described in the methods.
###end p 108
###begin p 109
###xml 68 69 68 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 69 70 69 70 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 86 87 86 87 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 108 110 108 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tb</italic>
###xml 119 121 119 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tc</italic>
###xml 182 193 182 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. donovani</italic>
###xml 193 197 193 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib29" ref-type="bibr">[29]</xref>
###xml 202 210 202 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. cruzi</italic>
###xml 210 217 210 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib12 bib31" ref-type="bibr">[12,31]</xref>
###xml 182 193 <span type="species:ncbi:5661">L. donovani</span>
###xml 202 210 <span type="species:ncbi:5693">T. cruzi</span>
Trypanothione reductase spectral properties and kinetic parameters. Km values for T(S)2 were determined for TbTryR and TcTryR in both the 340 and 412 nm assays. Additional data from L. donovani[29] and T. cruzi[12,31].
###end p 109
###begin p 110
n.d.: not determined.
###end p 110
###begin p 111
###xml 73 85 73 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. b. brucei</italic>
###xml 90 98 90 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. cruzi</italic>
###xml 124 136 124 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. b. brucei</italic>
###xml 142 143 142 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</italic>
###xml 150 152 150 152 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 168 170 168 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tb</italic>
###xml 179 181 179 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tc</italic>
###xml 253 255 253 255 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 288 289 288 289 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 297 298 297 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 298 299 298 299 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 314 316 313 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tb</italic>
###xml 338 340 336 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tc</italic>
###xml 366 372 364 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">Fig. 4</xref>
###xml 406 408 404 406 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 413 415 411 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tb</italic>
###xml 429 431 427 429 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 436 445 434 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. brucei</italic>
###xml 482 483 480 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 483 484 481 482 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 76 85 <span type="species:ncbi:497498">b. brucei</span>
###xml 90 98 <span type="species:ncbi:5693">T. cruzi</span>
###xml 127 136 <span type="species:ncbi:497498">b. brucei</span>
###xml 436 445 <span type="species:ncbi:5691">T. brucei</span>
Potency of representative compounds against trypanothione reductase from T. b. brucei and T. cruzi and growth inhibition of T. b. brucei cells. All IC50 values against TbTryR and TcTryR were determined in the 412 nm assay on three separate occasions. IC50 values were determined with T(S)2 at S = Km (2.35 muM for TbTryR and 10.4 muM for TcTryR). For structures see Fig. 4. Linear regression analysis of IC50 for TbTryR versus EC50 for T. brucei yielded a regression coefficient of r2 = 0.49.
###end p 111
###begin p 112
###xml 28 32 28 32 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib33" ref-type="bibr">[33]</xref>
Data from Richardson et al. [33].
###end p 112
###begin p 113
###xml 24 28 24 28 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib19" ref-type="bibr">[19]</xref>
Data from Martyn et al. [19].
###end p 113
###begin p 114
Crystallography statistics.
###end p 114
###begin p 115
The numbers in parentheses refer to the highest resolution bin (2.36-2.30 A).
###end p 115

